Recombinant Escherichia coli O45:K1 Queuine tRNA-ribosyltransferase (tgt)

What is the primary function of tRNA-guanine transglycosylase (TGT) in E. coli?

TGT (EC 2.4.2.29) catalyzes a posttranscriptional transglycosylation reaction that exchanges guanine (G) at position 34 (the wobble position) with the modified base preQ1 (7-aminomethyl-7-deazaguanine) in specific tRNAs. This modification occurs specifically in tRNAs with GUN anticodons: tRNAAsn, tRNAAsp, tRNAHis, and tRNATyr . The inserted preQ1 is subsequently modified to epoxyqueuosine (oQ) by QueA enzyme, and finally reduced to queuosine (Q) by QueG . This modification pathway is part of a complex post-transcriptional RNA modification system that influences translational accuracy and efficiency.

What structural domains are essential for E. coli TGT activity?

Based on structural and functional studies, E. coli TGT contains several critical domains:

• The active site domain featuring the catalytically essential aspartate 89 residue that functions as a nucleophile

• A specific binding pocket for preQ1 substrate that ensures proper orientation for the exchange reaction

• A tRNA recognition domain that facilitates binding to the correct tRNA substrates

• A zinc-binding domain that contributes to structural stability of the protein

What are the most effective methods for expressing recombinant E. coli TGT?

For optimal expression of functionally active recombinant E. coli TGT:

• Expression system:

  • Use E. coli BL21(DE3) or similar strains with low protease activity

  • Select a pET-based vector system with T7 promoter control

  • Include an N-terminal His6 tag for purification with minimal impact on enzyme activity

• Expression conditions:

  • Grow cultures at 37°C until OD600 reaches 0.6-0.8

  • Induce with 0.5-1.0 mM IPTG

  • Shift temperature to 18-25°C post-induction and continue for 16-18 hours

  • Supplement with 50 μM ZnCl2 to ensure proper folding of the zinc-binding domain

• Cell lysis and initial purification:

  • Use buffer containing 50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 5-10 mM imidazole, and 2 mM DTT

  • Add protease inhibitors to prevent degradation during purification

  • Include RNase treatment to remove bound cellular RNAs

How can the enzymatic activity of recombinant E. coli TGT be measured accurately?

Several methods are available for measuring TGT activity, each with specific advantages:

• Radiochemical assay:

  • Incorporate radiolabeled substrates ([14C]-guanine or preQ1)

  • Monitor incorporation into tRNA or release from tRNA

  • Quantify by scintillation counting or phosphorimaging

  • Provides highly sensitive quantitative measurement

• Acryloylaminophenyl boronic acid (APB) gel electrophoresis:

  • Separates Q-modified from unmodified tRNAs

  • Combine with Northern blotting for specific tRNA detection

  • Provides semi-quantitative assessment of modification levels

• Direct RNA sequencing via nanopore technology:

  • Detects Q and Q precursors in tRNAs at single-base resolution

  • Compares error profiles between modified and unmodified tRNAs

  • Analyze with specialized software like JACUSA2 to detect modifications

  • Particularly useful for in vivo studies and analysis of natural samples

What detection methods are available for monitoring queuosine incorporation into tRNA?

The following methods provide varying levels of resolution and specificity:

How do specific mutations in the active site of E. coli TGT affect its catalytic efficiency?

Systematic mutagenesis studies of the E. coli TGT active site have revealed specific structure-function relationships:

• Aspartate 89 mutations:

  • D89E: Retains significant activity with kinetic parameters comparable to wild-type, demonstrating tolerance for the position of the carboxylate group

  • D89A, D89N, D89C: Show approximately 1000-fold lower activity than wild-type, confirming the essential role of the carboxylate group in catalysis

  • These results strongly support an associative catalytic mechanism where D89 acts as a nucleophile

• Active site binding pocket mutations (based on structural homology):

  • Alterations to residues that interact with preQ1 can change substrate specificity

  • Modifications to the base recognition pocket can affect discrimination between guanine and modified bases

• Effect on kinetic parameters:

  • Conservative mutations like D89E maintain comparable kcat and Km values to wild-type

  • Non-conservative changes typically affect both substrate binding and catalytic turnover

  • The glutamate mutant was the only variant able to form a stable complex with RNA substrate under denaturing conditions similar to wild-type

What is the role of aspartate 89 in the catalytic mechanism of E. coli TGT?

Aspartate 89 plays a central nucleophilic role in the catalytic mechanism of E. coli TGT:

• Mechanistic function:

  • Acts as a nucleophile in an associative catalytic mechanism

  • Attacks the C1' of the ribose moiety of the target nucleoside in tRNA

  • Forms a covalent enzyme-RNA intermediate during catalysis

• Experimental evidence:

  • Mutation studies demonstrate that replacing D89 with glutamate (D89E) maintains activity

  • Alanine, asparagine, and cysteine substitutions severely impair function

  • The D89E mutant forms a stable complex with RNA substrate under denaturing conditions, similar to wild-type

  • Kinetic parameters of D89E are comparable to wild-type, suggesting tolerance for the positioning of the carboxylate group

• Rejection of alternative mechanism:

  • A dissociative mechanism was previously proposed where D89 would provide electrostatic stabilization of an oxocarbenium ion intermediate

  • The poor activity of D89A, D89N, and D89C mutants contradicts this hypothesis

  • The data overwhelmingly supports the nucleophilic role of D89 in an associative mechanism

How does bacterial TGT differ from eukaryotic queuine tRNA-ribosyltransferase?

Despite catalyzing similar reactions, bacterial and eukaryotic enzymes exhibit significant differences:

Eukaryotic QTRT1 has been implicated in cancer progression, particularly in lung adenocarcinoma (LUAD) where its expression is significantly increased compared to normal tissue . Expression analysis from multiple datasets shows that QTRT1 is upregulated in LUAD tissues, while its methylation is decreased .

What are common challenges in producing functionally active recombinant E. coli TGT?

Researchers frequently encounter these challenges when working with recombinant E. coli TGT:

• Protein solubility issues:

  • TGT can form inclusion bodies when overexpressed

  • Solutions include lowering induction temperature (18-25°C), using solubility-enhancing tags, or co-expressing with chaperones

• Maintaining structural integrity:

  • The zinc-binding domain is crucial for proper folding

  • Ensure adequate zinc availability in the growth medium (50-100 μM ZnCl2)

  • Include zinc in purification buffers to maintain structural integrity

• Endogenous tRNA contamination:

  • TGT can co-purify with cellular tRNAs during expression

  • Include high salt washes (500 mM NaCl) and RNase treatment during purification

  • Verify enzyme preparation purity by measuring A260/A280 ratio (should be <0.7)

• Enzyme stability concerns:

  • Active site residues can be susceptible to oxidation

  • Include reducing agents (DTT, β-mercaptoethanol) in all buffers

  • Store enzyme in buffer containing 50% glycerol at -20°C for optimal stability

How can the efficiency of in vitro queuosinylation reactions be optimized?

To achieve maximum efficiency in in vitro queuosinylation reactions with E. coli TGT:

• Reaction parameters:

  • Temperature: 30°C provides the best balance between activity and stability

  • pH: Maintain at 7.5 for optimal reaction rates

  • Incubation time: 7 hours for complete modification

• Optimal buffer composition:

  • 50 mM Tris-HCl (pH 7.5)

  • 20 mM NaCl

  • 5 mM MgCl2

  • 2 mM DTT

• Substrate preparation:

  • tRNA concentration: 10 μM for standard reactions

  • preQ1 concentration: 20-50 μM provides saturating conditions

  • Ensure proper tRNA folding by heating to 65°C and cooling slowly in the presence of Mg2+

• Enzyme considerations:

  • Use freshly purified enzyme when possible

  • Enzyme:tRNA ratio: Use 200 nM enzyme for 10 μM tRNA substrate

  • Pre-incubate enzyme in reaction buffer before adding substrates

• Reaction monitoring:

  • Monitor progress using APB gel electrophoresis or direct RNA sequencing

  • Purify modified tRNAs by phenol-chloroform extraction and ethanol precipitation

How does the queuine modification pathway in E. coli interconnect with other cellular processes?

The queuine modification pathway connects with several important cellular processes:

• Translation and codon recognition:

  • Q-modified tRNAs show altered codon recognition properties

  • Affects translation efficiency and accuracy, particularly at NAU/C codons

  • Influences gene expression under different environmental conditions

• Stress response:

  • Q modification levels change in response to nutrient availability and stress

  • May serve as a regulatory mechanism for stress adaptation

• Metabolic integration:

  • The biosynthetic pathway from GTP to preQ0 to preQ1 connects with purine metabolism

  • Requires significant cellular resources, including NADPH for the QueF-catalyzed reduction

  • The pathway is regulated in response to cellular energy status

• Evolutionary significance:

  • The pathways for Q modification differ between bacteria and eukaryotes

  • Eukaryotes depend on external sources of queuine, suggesting an evolutionary relationship with bacteria

What are potential research applications for recombinant E. coli TGT?

Recombinant E. coli TGT has several valuable research applications:

• RNA modification studies:

  • Tool for site-specific modification of tRNAs to study effects on translation

  • Creation of specifically modified tRNAs for structural and functional studies

  • Investigation of Q modification's role in codon-anticodon interactions

• Biophysical and structural studies:

  • Model system for understanding transglycosylase mechanisms

  • Crystallography and cryo-EM studies of enzyme-tRNA interactions

  • Investigation of catalytic mechanisms through modified substrates

• Cancer research:

  • Understanding connections between tRNA modifications and cancer pathogenesis

  • Development of tools to study QTRT1 in lung adenocarcinoma and other cancers

  • Potential biomarker development based on tRNA modification patterns

• Biotechnology applications:

  • Engineering specialized tRNAs with modified bases for synthetic biology

  • Development of reporter systems based on Q-modified tRNAs

  • Potential biotechnological applications in RNA modification technologies